Anti-Borreliella burgdorferi ospA Antibody (SAA2243) from ProteoGenix; catalogue ARO-A22864; research use only.
Know who made it. See the evidence. Buy through one marketplace.
A powerful tool for your biotech research needs.
This highly specific antibody targets the outer surface protein A (OspA) of the Borreliella burgdorferi bacterium, the causative agent of Lyme disease. It is a monoclonal antibody that has been extensively validated for its high affinity and specificity towards OspA.
The Anti-Borreliella burgdorferi ospA Antibody (SAA2243) works by binding to the OspA protein, preventing its interaction with host cells and inhibiting the bacterium’s ability to cause infection. This makes it an essential tool for studying the pathogenesis of Lyme disease and developing potential treatments.
This antibody is ideal for use in various applications, including Western blotting, ELISA, immunohistochemistry, and flow cytometry. It has been successfully used in both in vitro and in vivo studies, providing reliable and reproducible results.
The Anti-Borreliella burgdorferi ospA Antibody (SAA2243) has been used in numerous research studies to investigate the role of OspA in Lyme disease. It has been shown to effectively block the transmission of the bacterium from ticks to host animals, providing crucial insights into the disease’s pathogenesis. Additionally, it has been used to study the immune response to OspA and its potential as a vaccine candidate.
With its high specificity and versatility, this antibody is a valuable tool for any researcher studying Lyme disease and its causative agent, Borreliella burgdorferi.
In summary, the Anti-Borreliella burgdorferi ospA Antibody (SAA2243) offers a reliable and effective means of targeting OspA in various research applications. Its proven track record in numerous studies makes it a top choice for scientists looking to advance their understanding of Lyme disease. Order yours today and take a step towards groundbreaking discoveries in biotech research.
ProteoGenix catalogue number ARO-A22864. For research use only.
Target: Outer surface protein A, ospA; Clonality: Monoclonal Antibody; Applications: ELISA.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA |
|---|---|---|---|---|---|---|---|---|
| Outer surface protein A, ospA |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
